Earnings Estimates Moving Higher for Horizon Pharma (HZNP): Time to Buy?

Zacks

Specialty pharmaceutical company Horizon Pharma, Inc. (HZNP) could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on HZNP’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Horizon Pharma could be a solid choice for investors.

Current Quarter Estimates for HZNP

In the past 30 days, 1 estimate has gone higher for Horizon Pharma while none moved lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 15 cents a share 30 days ago, to a loss of 9 cents today, a move of 40.0%.

Current Year Estimates for HZNP

Meanwhile, Horizon Pharma’s current year figures are also looking quite promising, with 2 estimates moving higher in the past month, compared to no downward revision. The consensus estimate trend has also seen a boost for this time frame, narrowing from $1.01 per share 30 days ago to 84 cents per share today, an increase of 16.8%.

Bottom Line

The stock has also started to move higher lately, adding 40.6% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 DaysClick to get this free report >>




HORIZON PHARMA INC (HZNP): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)